Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
117.99
+1.99 (1.72%)
At close: May 13, 2026, 4:00 PM EDT
117.29
-0.70 (-0.59%)
Pre-market: May 14, 2026, 6:06 AM EDT

Insmed Revenue

Insmed had revenue of $305.96M in the quarter ending March 31, 2026, with 229.62% growth. This brings the company's revenue in the last twelve months to $819.56M, up 115.09% year-over-year. In the year 2025, Insmed had annual revenue of $606.42M with 66.73% growth.

Revenue (ttm)
$819.56M
Revenue Growth
+115.09%
P/S Ratio
31.21
Revenue / Employee
$492,526
Employees
1,664
Market Cap
25.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.42M242.72M66.73%
Dec 31, 2024363.71M58.50M19.17%
Dec 31, 2023305.21M59.85M24.39%
Dec 31, 2022245.36M56.90M30.19%
Dec 31, 2021188.46M24.05M14.63%
Dec 31, 2020164.41M27.95M20.48%
Dec 31, 2019136.47M126.63M1,287.56%
Dec 31, 20189.84M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 201311.50M--
Dec 31, 2012---
Dec 31, 20114.42M-2.50M-36.18%
Dec 31, 20106.92M-3.45M-33.28%
Dec 31, 200910.37M-1.33M-11.33%
Dec 31, 200811.70M4.12M54.32%
Dec 31, 20077.58M6.56M639.61%
Dec 31, 20061.03M894.00K682.44%
Dec 31, 2005131.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.74B
Incyte5.36B
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioNTech SE3.23B
Royalty Pharma2.44B
Moderna2.23B
Ascendis Pharma998.25M
Revenue Rankings